Vaccine Adjuvants Market Report 2026

Vaccine Adjuvants Market Overview

• Vaccine Adjuvants market size has reached to $2.01 billion in 2025 • Expected to grow to $3.13 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Elevated Funding For Vaccine Research Initiatives Catalyst For Growth In The Vaccine Adjuvants Market • Market Trend: Advancing Vaccine Development Through Sustainable Cultured-Plant-Cell Adjuvant Innovation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vaccine Adjuvants Market?

Vaccine adjuvants are compounds or ingredients used in vaccines that enhance the body's immunogenic response to antigens that lack immunostimulatory capabilities and help to create a stronger immune response. The main types of products of vaccine adjuvants are adjuvant emulsions, pathogen components, particulate adjuvants, combination adjuvants, and others such as saponin-based adjuvants. An adjuvant emulsion is a mixture of two or more ordinarily immiscible liquids. The route of application includes human vaccine adjuvants and veterinary vaccine adjuvants administered through oral, intramuscular, intranasal, subcutaneous, and intradermal routes to treat cancer, infectious diseases, and other diseases including zoonotic diseases.

What Is The Vaccine Adjuvants Market Growth Forecast?

The vaccine adjuvants market size is expected to see strong growth in the next few years. It will grow to $3.13 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rising demand for human and veterinary vaccines, increasing focus on cancer and infectious disease immunotherapies, innovations in nanoparticle and liposome adjuvants, regulatory support for novel adjuvants, expansion of biologics manufacturing infrastructure. Major trends in the forecast period include personalized vaccine adjuvant development, novel immunostimulatory compounds, multi-disease targeted adjuvants, enhanced safety and efficacy profiles, rapid vaccine formulation platforms.

Global Vaccine Adjuvants Market Segmentation

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types 2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants 3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal 4) By Disease: Cancer, Infectious Diseases, Other Diseases Subsegments: 1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions 2) By Pathogen Components: Bacterial Components, Viral Components 3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles 4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems 5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

What Is The Driver Of The Vaccine Adjuvants Market?

The growing funding for vaccine research activities is expected to propel the growth of the vaccine adjuvants market going forward. Vaccine research activities can be defined as comprehensive scientific endeavors aimed at developing, testing, and improving vaccines to prevent infectious diseases. Research activities play a vital role in developing, testing, and optimizing potential adjuvant candidates from various sources, including natural products, synthetic compounds, and even bacteria or viruses. For instance, in October 2023, the United States Department of Health and Human Services, a US-based provider of essential human services, announced Project NextGen with a $500 million investment to begin developing phase 2b clinical trial plans and technologies that develop cutting-edge next-generation vaccination and treatment platforms. Therefore, the growing funding for vaccine research activities is driving the growth of the vaccine adjuvants industry.

Key Players In The Global Vaccine Adjuvants Market

Major companies operating in the vaccine adjuvants market are GlaxoSmithKline Plc., Novavax Inc., Agenus Inc., CSL Limited, Adjuvatis, Merck KGaA, Seppic Inc., Virometix AG, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc.

Global Vaccine Adjuvants Market Trends and Insights

Major companies operating in the vaccine adjuvants market are focusing on technological advancements, such as cultured-plant-cell QS-21 (cpcQS-21), to meet the rising demand for more sustainable and scalable production of potent immune-stimulatory adjuvants. QS-21 is a potent saponin adjuvant traditionally extracted from the bark of Quillaja saponaria trees; unlike conventional aluminum-based adjuvants, QS-21 elicits both strong antibody and cellular immune responses, but its supply is limited by the scarcity of tree bark and variability in quality. In August 2024, SaponiQx, a US-based biomanufacturing company, launched STIMULON cultured plant cell QS-21, a cpcQS-21 adjuvant available for commercial purchase through InvivoGen. This product is produced via plant cell culture rather than tree bark, ensuring consistent and scalable supply; it offers high purity, lot-to-lot uniformity, and reduced environmental impact. Functionally, STIMULON cpcQS-21 retains the same immunostimulatory potency as tree-derived QS-21 in driving both humoral and cellular immune responses, making it suitable for use in vaccines for infectious diseases such as malaria, shingles, and RSV.

What Are Latest Mergers And Acquisitions In The Vaccine Adjuvants Market?

In July 2024, SPI Pharma Inc., a US-based provider of pharmaceutical excipients, vaccine adjuvant systems, and formulation solutions, partnered with Inimmune Corp. to expand its vaccine adjuvant capabilities by co-developing innovative immune-modulating systems, enhancing its technological portfolio and accelerating time-to-market for next-generation vaccines. Inimmune Corp. is a US-based biotechnology company specializing in innate immune modulators and advanced adjuvant technologies for vaccine development.

Regional Insights

North America was the largest region in the vaccine adjuvants market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Vaccine Adjuvants Market?

The vaccine adjuvants market consists of sales of adjuvant emulsions, pathogen components, particulate adjuvants, combination adjuvants, and saponin-based adjuvants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vaccine Adjuvants Market Report 2026?

The vaccine adjuvants market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vaccine adjuvants industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.